Filing Details

Accession Number:
0001209191-14-070681
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-21 18:02:22
Reporting Period:
2014-11-20
Filing Date:
2014-11-21
Accepted Time:
2014-11-21 18:02:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage C/O Retrophin, Inc.
777 Third Avenue, 22Nd Floor
New York NY 10017
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-20 1,300 $8.20 363,056 No 4 P Direct
Common Stock Acquisiton 2014-11-21 8,700 $8.50 371,756 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct